Skip to main content

You are here

Current Investments



Diversigen provides sequencing and analysis solutions and consulting services for the study of the microbiome of living organisms and environments. Our years of experience on diverse projects, combined with our flexible sequencing and bioinformatic capacity help us cater to our customers’ needs, including development of techniques for handling low biomass, more sensitive levels of QA/QC, and personalized customer service, regardless of target or sample type.

Synced Care

Synced Care

Founded in 2013 by BCM surgeons, Synced Care focuses on increasing patient compliance with pre and post-op surgical protocols.  The goal is to improve patient outcomes and reduce provider costs related to high readmission rates.

Step Stone


Expand clinical knowledge with a more effective and engaging way to learn with StepStoneMed's platform-independent software.  Personnel responsible for any level of patient care (physicians, nurses, medical students, aides, and volunteers) can acquire and retain clinical knowledge and recall patient care protocols easier with StepStoneMed.


Kardia Therapeutics, Inc.

Kardia Therapeutics, Inc. is a research-stage biotechnology company focused on the development of cardiac regenerative therapies in the areas myocardial infarction and heart failure. Kardia Therapeutics’ portfolio of technologies utilizes three related approaches: 1) Adult Cardiac Progenitor Cells, 2) Stem Cell Optimization Technologies, and 3) Homing/Growth Factor Therapies. Because the heart has a limited capacity for self-regeneration, Kardia’s technologies have the potential to offer significantly improved patient outcomes compared to existing treatments.  For additional information, please contact Dr. Caroline Popper.


Kryptiq Corporation

Kryptiq is the leading provider of workflow connectivity solutions for healthcare. Kryptiq streamlines healthcare communications among patients, providers, pharmacies, and healthplans with secure messaging, electronic prescribing, disease management, and contract management technologies. By integrating these solutions with existing systems and applications, Kryptiq enables the trusted transport of health information where and when it is needed.

Molecular Logix, Inc.

MLX is a drug discovery company located in The Woodlands, Texas that seeks to discover novel therapeutics through the application of rationale protein engineering technologies. The company is currently developing protein-based drugs to treat cancer by interfering with established tumor growth factor pathways.


Opexa Therapeutics

Opexa Therapeutics is a publicly-traded cellular therapy company located in The Woodlands, TX with two proprietary, broad technical therapeutic platforms: T-cell vaccination and autologous stem cell therapy. Opexa Therapeutics is developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, cardiovascular disease, and diabetes.

Progression Therapeutics

Progression Therapeutics is a biotechnology company focused on the treatment of primary and metastatic cancer. The Company currently has multiple products in various stages of evaluation, including a novel tumor suppressor gene product that has demonstrated potent anti-tumor activity, both in vitro and in vivo. For additional information, contact Dr. Caroline Popper.


Relievant MedSystems

Relievant MedSystems is a medical device company developing novel products to treat lower back pain using a minimally invasive therapeutic approach. The company was founded in 2004 and is headquartered in San Francisco, California.